lutein has been researched along with 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine in 1 studies
| Studies (lutein) | Trials (lutein) | Recent Studies (post-2010) (lutein) | Studies (1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine) | Trials (1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine) | Recent Studies (post-2010) (1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine) |
|---|---|---|---|---|---|
| 2,770 | 267 | 1,422 | 60 | 1 | 21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ademowo, OS; Devitt, A; Dias, HKI; Griffiths, HR; Howard, AN; Milic, I; Moran, R; Mulcahy, R; Nolan, JM | 1 |
1 other study(ies) available for lutein and 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine
| Article | Year |
|---|---|
Phospholipid oxidation and carotenoid supplementation in Alzheimer's disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Biomarkers; Carotenoids; Cognition Disorders; Combined Modality Therapy; Dietary Supplements; Female; Humans; Lipid Peroxidation; Lutein; Male; Oxidation-Reduction; Phospholipid Ethers; Phospholipids; Reactive Oxygen Species; Zeaxanthins | 2017 |